BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bergheim I, Guo L, Davis MA, Lambert JC, Beier JI, Duveau I, Luyendyk JP, Roth RA, Arteel GE. Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1. Gastroenterology 2006;130:2099-112. [PMID: 16762632 DOI: 10.1053/j.gastro.2006.03.020] [Cited by in Crossref: 144] [Cited by in F6Publishing: 142] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 de Larrañaga G, Wingeyer SP, Graffigna M, Belli S, Bendezú K, Alvarez S, Levalle O, Fainboim H. Plasma Plasminogen Activator Inhibitor-1 Levels and Nonalcoholic Fatty Liver in Individuals With Features of Metabolic Syndrome. Clin Appl Thromb Hemost 2008;14:319-24. [DOI: 10.1177/1076029607304094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
2 Zeng T, Xie KQ. Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis. Arch Toxicol. 2009;83:1075-1081. [PMID: 19588123 DOI: 10.1007/s00204-009-0457-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
3 Beier J, Arteel G. Ethanol-Induced Hepatotoxicity. Comprehensive Toxicology. Elsevier; 2010. pp. 421-35. [DOI: 10.1016/b978-0-08-046884-6.01017-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Breitkopf K, Nagy LE, Beier JI, Mueller S, Weng H, Dooley S. Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol Clin Exp Res. 2009;33:1647-1655. [PMID: 19645734 DOI: 10.1111/j.1530-0277.2009.01015.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wagnerberger S, Fiederlein L, Kanuri G, Stahl C, Millonig G, Mueller S, Bischoff SC, Bergheim I. Sex-specific differences in the development of acute alcohol-induced liver steatosis in mice. Alcohol Alcohol. 2013;48:648-656. [PMID: 23969550 DOI: 10.1093/alcalc/agt138] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
6 Gyamfi MA, He L, French SW, Damjanov I, Wan YJ. Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury. J Pharmacol Exp Ther. 2008;324:443-453. [PMID: 17975011 DOI: 10.1124/jpet.107.132258] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
7 Fitzpatrick E, Dew TK, Quaglia A, Sherwood RA, Mitry RR, Dhawan A. Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2012;7:471-479. [PMID: 22962039 DOI: 10.1111/j.2047-6310.2012.00082.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
8 Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease. IUBMB Life. 2008;60:790-797. [PMID: 18709650 DOI: 10.1002/iub.124] [Cited by in Crossref: 88] [Cited by in F6Publishing: 89] [Article Influence: 6.8] [Reference Citation Analysis]
9 Ju KD, Kim HJ, Tsogbadrakh B, Lee J, Ryu H, Cho EJ, Hwang Y, Kim K, Yang J, Ahn C, Oh K. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis. American Journal of Physiology-Renal Physiology 2016;310:F342-50. [DOI: 10.1152/ajprenal.00204.2015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hamaguchi E, Takamura T, Sakurai M, Mizukoshi E, Zen Y, Takeshita Y, Kurita S, Arai K, Yamashita T, Sasaki M, Nakanuma Y, Kaneko S. Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis. Diabetes Care 2010;33:284-6. [PMID: 19880582 DOI: 10.2337/dc09-0148] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
11 Chen MM, Carter SR, Curtis BJ, O'Halloran EB, Gamelli RL, Kovacs EJ. Alcohol Modulation of the Postburn Hepatic Response. J Burn Care Res 2017;38:e144-57. [PMID: 26284631 DOI: 10.1097/BCR.0000000000000279] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Trogen G, Bacon J, Li Y, Wright GL, Degroat A, Hagood KL, Warren Z, Forsman A, Kilaru A, Clark WA, Peterson JM. Transgenic overexpression of CTRP3 prevents alcohol-induced hepatic triglyceride accumulation. Am J Physiol Endocrinol Metab 2018;315:E949-60. [PMID: 29763374 DOI: 10.1152/ajpendo.00050.2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
13 Boye A, Zou YH, Yang Y. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies? World J Gastroenterol 2016; 22(1): 50-71 [PMID: 26755860 DOI: 10.3748/wjg.v22.i1.50] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
14 Beier JI, McClain CJ. Mechanisms and cell signaling in alcoholic liver disease. Biol Chem 2010;391:1249-64. [PMID: 20868231 DOI: 10.1515/BC.2010.137] [Cited by in Crossref: 112] [Cited by in F6Publishing: 101] [Article Influence: 10.2] [Reference Citation Analysis]
15 Kaiser JP, Beier JI, Zhang J, David Hoetker J, von Montfort C, Guo L, Zheng Y, Monia BP, Bhatnagar A, Arteel GE. PKCepsilon plays a causal role in acute ethanol-induced steatosis. Arch Biochem Biophys. 2009;482:104-111. [PMID: 19022218 DOI: 10.1016/j.abb.2008.11.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
16 Cho K, Chung JY, Cho SK, Shin HW, Jang IJ, Park JW, Yu KS, Cho JY. Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway. Sci Rep 2015;5:8145. [PMID: 25634597 DOI: 10.1038/srep08145] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 7.6] [Reference Citation Analysis]
17 Yu S, Li C, Ji G, Zhang L. The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease. Front Pharmacol 2021;12:783393. [PMID: 34867414 DOI: 10.3389/fphar.2021.783393] [Reference Citation Analysis]
18 Guo R, Scott GI, Ren J. Involvement of AMPK in alcohol dehydrogenase accentuated myocardial dysfunction following acute ethanol challenge in mice. PLoS One 2010;5:e11268. [PMID: 20585647 DOI: 10.1371/journal.pone.0011268] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
19 Wang M, Zhang X, Liu F, Hu Y, He C, Li P, Su H, Wan J. Saponins isolated from the leaves of Panax notoginseng protect against alcoholic liver injury via inhibiting ethanol-induced oxidative stress and gut-derived endotoxin-mediated inflammation. Journal of Functional Foods 2015;19:214-24. [DOI: 10.1016/j.jff.2015.09.029] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 5.1] [Reference Citation Analysis]
20 Chuang HY, Ng LT, Lin LT, Chang JS, Chen JY, Lin TC, Lin CC. Hydrolysable tannins of tropical almond show antifibrotic effects in TGF-β1-induced hepatic stellate cells. J Sci Food Agric. 2011;91:2777-2784. [PMID: 21725979 DOI: 10.1002/jsfa.4521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
21 Massey VL, Arteel GE. Acute alcohol-induced liver injury. Front Physiol 2012;3:193. [PMID: 22701432 DOI: 10.3389/fphys.2012.00193] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
22 Zhu Z, Jiang Z, Zhou J, Zhou D, Wang W, Zhao C, Zhen Z, Nanji AA. Involvement of insulin resistance in the protective effect of metformin against alcoholic liver injury. Alcohol Clin Exp Res. 2014;38:1510-1519. [PMID: 24797033 DOI: 10.1111/acer.12418] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
23 Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med. 2008;44:1259-1272. [PMID: 18242193 DOI: 10.1016/j.freeradbiomed.2007.12.029] [Cited by in Crossref: 291] [Cited by in F6Publishing: 274] [Article Influence: 20.8] [Reference Citation Analysis]
24 Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008;138:1452-5. [PMID: 18641190 DOI: 10.1093/jn/138.8.1452] [Cited by in Crossref: 289] [Cited by in F6Publishing: 270] [Article Influence: 20.6] [Reference Citation Analysis]
25 von Montfort C, Beier JI, Kaiser JP, Guo L, Joshi-Barve S, Pritchard MT, States JC, Arteel GE. PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division. Am J Physiol Gastrointest Liver Physiol 2010;298:G657-66. [PMID: 20203062 DOI: 10.1152/ajpgi.00107.2009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
26 Sozio M, Crabb DW. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab. 2008;295:E10-E16. [PMID: 18349117 DOI: 10.1152/ajpendo.00011.2008] [Cited by in Crossref: 133] [Cited by in F6Publishing: 125] [Article Influence: 9.5] [Reference Citation Analysis]
27 Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells. Lab Invest 2011;91:885-95. [PMID: 21423135 DOI: 10.1038/labinvest.2011.44] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
28 Beier JI, Guo L, von Montfort C, Kaiser JP, Joshi-Barve S, Arteel GE. New role of resistin in lipopolysaccharide-induced liver damage in mice. J Pharmacol Exp Ther. 2008;325:801-808. [PMID: 18339969 DOI: 10.1124/jpet.108.136721] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
29 Horiuchi T, Sakata N, Narumi Y, Kimura T, Hayashi T, Nagano K, Liu K, Nishibori M, Tsukita S, Yamada T, Katagiri H, Shirakawa R, Horiuchi H. Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity. J Biol Chem 2017;292:8436-46. [PMID: 28373282 DOI: 10.1074/jbc.M116.769380] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
30 Massey VL, Dolin CE, Poole LG, Hudson SV, Siow DL, Brock GN, Merchant ML, Wilkey DW, Arteel GE. The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice. Hepatology 2017;65:969-82. [PMID: 28035785 DOI: 10.1002/hep.28918] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
31 Aziz Q, Thomas A, Khambra T, Tinker A. Phenformin has a direct inhibitory effect on the ATP-sensitive potassium channel. Eur J Pharmacol 2010;634:26-32. [PMID: 20188727 DOI: 10.1016/j.ejphar.2010.02.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
32 Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009;33:191-205. [PMID: 19032584 DOI: 10.1111/j.1530-0277.2008.00827.x] [Cited by in Crossref: 191] [Cited by in F6Publishing: 187] [Article Influence: 13.6] [Reference Citation Analysis]
33 Patel F, Parwani K, Patel D, Mandal P. Metformin and Probiotics Interplay in Amelioration of Ethanol-Induced Oxidative Stress and Inflammatory Response in an In Vitro and In Vivo Model of Hepatic Injury. Mediators Inflamm 2021;2021:6636152. [PMID: 33953643 DOI: 10.1155/2021/6636152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Keshavarzi S, Kermanshahi S, Karami L, Motaghinejad M, Motevalian M, Sadr S. Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways. NeuroToxicology 2019;72:74-84. [DOI: 10.1016/j.neuro.2019.02.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
35 Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, Mcclain CJ, Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin. Journal of Hepatology 2008;48:983-92. [DOI: 10.1016/j.jhep.2008.01.035] [Cited by in Crossref: 340] [Cited by in F6Publishing: 322] [Article Influence: 24.3] [Reference Citation Analysis]
36 Xiao H, Ma X, Feng W, Fu Y, Lu Z, Xu M, Shen Q, Zhu Y, Zhang Y. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc Res 2010;87:504-13. [PMID: 20200042 DOI: 10.1093/cvr/cvq066] [Cited by in Crossref: 139] [Cited by in F6Publishing: 141] [Article Influence: 11.6] [Reference Citation Analysis]
37 Da Silva Morais A, Lebrun V, Abarca-Quinones J, Brichard S, Hue L, Guigas B, Viollet B, Leclercq IA. Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation. J Hepatol 2009;50:489-500. [PMID: 19155087 DOI: 10.1016/j.jhep.2008.10.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
38 Jeong W, Osei-hyiaman D, Park O, Liu J, Bátkai S, Mukhopadhyay P, Horiguchi N, Harvey-white J, Marsicano G, Lutz B, Gao B, Kunos G. Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver. Cell Metabolism 2008;7:227-35. [DOI: 10.1016/j.cmet.2007.12.007] [Cited by in Crossref: 221] [Cited by in F6Publishing: 208] [Article Influence: 15.8] [Reference Citation Analysis]
39 Liu H, Beier JI, Arteel GE, Ramsden CE, Feldstein AE, McClain CJ, Kirpich IA. Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease. Am J Pathol. 2015;185:43-54. [PMID: 25447051 DOI: 10.1016/j.ajpath.2014.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
40 Wu JT, Yang GW, Qi CH, Zhou L, Hu JG, Wang MS. ANTI-INFLAMMATORY ACTIVITY OF PLATYCODIN D ON ALCOHOL-INDUCED FATTY LIVER RATS VIA TLR4-MYD88-NF-κB SIGNAL PATH. Afr J Tradit Complement Altern Med 2016;13:176-83. [PMID: 28852734 DOI: 10.21010/ajtcam.v13i4.23] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
41 Shurrab NT, Arafa EA. Metformin: A review of its therapeutic efficacy and adverse effects. Obesity Medicine 2020;17:100186. [DOI: 10.1016/j.obmed.2020.100186] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
42 Isaacson RH, Beier JI, Khoo NK, Freeman BA, Freyberg Z, Arteel GE. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane. J Nutr Biochem 2020;81:108399. [PMID: 32388251 DOI: 10.1016/j.jnutbio.2020.108399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 Arteel GE. Animal models of alcoholic liver disease. Dig Dis 2010;28:729-36. [PMID: 21525757 DOI: 10.1159/000324280] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
44 Tomimoto A, Endo H, Sugiyama M, Fujisawa T, Hosono K, Takahashi H, Nakajima N, Nagashima Y, Wada K, Nakagama H, Nakajima A. Metformin suppresses intestinal polyp growth in ApcMin/+ mice. Cancer Sci. 2008;99:2136-2141. [PMID: 18803638 DOI: 10.1111/j.1349-7006.2008.00933.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 119] [Article Influence: 9.3] [Reference Citation Analysis]
45 Cho IJ, Oh DH, Yoo J, Hwang YC, Ahn KJ, Chung HY, Jeong SW, Moon JY, Lee SH, Lim SJ, Jeong IK. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. Sci Rep 2021;11:9894. [PMID: 33972568 DOI: 10.1038/s41598-021-88872-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Khoo NKH, Fazzari M, Chartoumpekis DV, Li L, Guimaraes DA, Arteel GE, Shiva S, Freeman BA. Electrophilic nitro-oleic acid reverses obesity-induced hepatic steatosis. Redox Biol 2019;22:101132. [PMID: 30769284 DOI: 10.1016/j.redox.2019.101132] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
47 Noh BK, Lee JK, Jun HJ, Lee JH, Jia Y, Hoang MH, Kim JW, Park KH, Lee SJ. Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase. Biochem Biophys Res Commun. 2011;414:361-366. [PMID: 21964292 DOI: 10.1016/j.bbrc.2011.09.077] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
48 Xavier DO, Amaral LS, Gomes MA, Rocha MA, Campos PR, Cota BD, Tafuri LS, Paiva AM, Silva JH, Andrade SP, Belo AV. Metformin inhibits inflammatory angiogenesis in a murine sponge model. Biomed Pharmacother 2010;64:220-5. [PMID: 20053525 DOI: 10.1016/j.biopha.2009.08.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
49 Patel F, Parwani K, Rao P, Patel D, Rawal R, Mandal P. Prophylactic Treatment of Probiotic and Metformin Mitigates Ethanol-Induced Intestinal Barrier Injury: In Vitro, In Vivo, and In Silico Approaches. Mediators Inflamm 2021;2021:5245197. [PMID: 34616233 DOI: 10.1155/2021/5245197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zhu L, Xiang S, Ou Z, Ma C, Yi X, Huang L, Ma Y, Liang Z, Yuan Z, Wen L, Li R, Wu J, Tan Z, Yi J. Gamma-oryzanol prevents ethanol-induced liver injury by ameliorating oxidative stress and modulating apoptosis-related protein expression in mice. Journal of Functional Foods 2019;62:103532. [DOI: 10.1016/j.jff.2019.103532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
51 Arteel GE. New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury. J Gastroenterol Hepatol. 2008;23 Suppl 1:S54-S59. [PMID: 18336665 DOI: 10.1111/j.1440-1746.2007.05285.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
52 Yang R, Guan MJ, Zhao N, Li MJ, Zeng T. Roles of extrahepatic lipolysis and the disturbance of hepatic fatty acid metabolism in TNF-α -induced hepatic steatosis. Toxicology 2019;411:172-80. [PMID: 30359672 DOI: 10.1016/j.tox.2018.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
53 Gyamfi MA, Wan YJ. Pathogenesis of alcoholic liver disease: the role of nuclear receptors. Exp Biol Med (Maywood). 2010;235:547-560. [PMID: 20463294 DOI: 10.1258/ebm.2009.009249] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
54 Kopec AK, Luyendyk JP. Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association? Semin Thromb Hemost 2016;42:397-407. [PMID: 27144445 DOI: 10.1055/s-0036-1579655] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
55 Hosono K, Endo H, Takahashi H, Sugiyama M, Uchiyama T, Suzuki K, Nozaki Y, Yoneda K, Fujita K, Yoneda M, Inamori M, Tomatsu A, Chihara T, Shimpo K, Nakagama H, Nakajima A. Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Mol Carcinog. 2010;49:662-671. [PMID: 20564343 DOI: 10.1002/mc.20637] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 10.2] [Reference Citation Analysis]
56 You M, Arteel GE. Effect of ethanol on lipid metabolism. J Hepatol 2019;70:237-48. [PMID: 30658725 DOI: 10.1016/j.jhep.2018.10.037] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 27.0] [Reference Citation Analysis]
57 Warner J, Hardesty J, Song Y, Sun R, Deng Z, Xu R, Yin X, Zhang X, McClain C, Warner D, Kirpich I. Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration. Front Pharmacol 2021;12:711590. [PMID: 34531743 DOI: 10.3389/fphar.2021.711590] [Reference Citation Analysis]
58 Qiu P, Li X, Kong DS, Li HZ, Niu CC, Pan SH. Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice. Evid Based Complement Alternat Med 2015;2015:613584. [PMID: 26101535 DOI: 10.1155/2015/613584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
59 Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2007;23:283-291. [PMID: 17414844 DOI: 10.1097/mog.0b013e3280f27582] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
60 Saeedi R, Parsons HL, Wambolt RB, Paulson K, Sharma V, Dyck JR, Brownsey RW, Allard MF. Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms. Am J Physiol Heart Circ Physiol 2008;294:H2497-506. [PMID: 18375721 DOI: 10.1152/ajpheart.00873.2007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
61 Engstler AJ, Aumiller T, Degen C, Dürr M, Weiss E, Maier IB, Schattenberg JM, Jin CJ, Sellmann C, Bergheim I. Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. Gut. 2016;65:1564-1571. [PMID: 26006114 DOI: 10.1136/gutjnl-2014-308379] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
62 Beier JI, Arteel GE. Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism. Exp Biol Med (Maywood) 2012;237:1-9. [PMID: 22238286 DOI: 10.1258/ebm.2011.011255] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
63 Shen Z, Li YM, Yu CH, Shen Y, Xu L, Xu CF, Chen JJ, Ye H, Xu GY. Risk factors for alcohol-related liver injury in the island population of China: A population-based case-control study. World J Gastroenterol 2008; 14(14): 2255-2261 [PMID: 18407605 DOI: 10.3748/wjg.14.2255] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
64 Kosone T, Takagi H, Horiguchi N, Ariyama Y, Otsuka T, Sohara N, Kakizaki S, Sato K, Mori M. HGF ameliorates a high-fat diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol. 2007;293:G204-G210. [PMID: 17395903 DOI: 10.1152/ajpgi.00021.2007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
65 Feng D, Wang Y, Mei Y, Xu Y, Xu H, Lu Y, Luo Q, Zhou S, Kong X, Xu L. Stearoyl-CoA desaturase 1 deficiency protects mice from immune-mediated liver injury. Lab Invest 2009;89:222-30. [DOI: 10.1038/labinvest.2008.105] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
66 Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Hepatology. 2008;48:109-118. [PMID: 18571789 DOI: 10.1002/hep.22338] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
67 Tan M, Schmidt RH, Beier JI, Watson WH, Zhong H, States JC, Arteel GE. Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. Toxicol Appl Pharmacol. 2011;257:356-364. [PMID: 21983427 DOI: 10.1016/j.taap.2011.09.019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
68 Yang RH, Xu Q, Qiao YY, Jia HZ, Shi XL. Experimental study of herbal-based medicine Hong Tian Gan Kang on the intervention and therapy for hepatic cirrhosis. Shijie Huaren Xiaohua Zazhi 2008; 16(6): 582-589 [DOI: 10.11569/wcjd.v16.i6.582] [Reference Citation Analysis]
69 Mercer PF, Chambers RC. Coagulation and coagulation signalling in fibrosis. Biochim Biophys Acta 2013;1832:1018-27. [PMID: 23298546 DOI: 10.1016/j.bbadis.2012.12.013] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
70 Li J, Yu H, Wang S, Wang W, Chen Q, Ma Y, Zhang Y, Wang T. Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism. Drug Des Devel Ther 2018;12:121-35. [PMID: 29391777 DOI: 10.2147/DDDT.S151860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
71 Kanuri G, Ladurner R, Skibovskaya J, Spruss A, Königsrainer A, Bischoff SC, Bergheim I. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. Liver Int. 2015;35:562-568. [PMID: 24351080 DOI: 10.1111/liv.12442] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
72 Iranshahy M, Rezaee R, Karimi G. Hepatoprotective activity of metformin: A new mission for an old drug? Eur J Pharmacol 2019;850:1-7. [PMID: 30753869 DOI: 10.1016/j.ejphar.2019.02.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
73 Roland AV, Moenter SM. Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthood. Endocrinology 2011;152:618-28. [PMID: 21159854 DOI: 10.1210/en.2010-0823] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
74 Lee SY, Ko KS. Effects of S-Adenosylmethionine and Its Combinations With Taurine and/or Betaine on Glutathione Homeostasis in Ethanol-induced Acute Hepatotoxicity. J Cancer Prev 2016;21:164-72. [PMID: 27722142 DOI: 10.15430/JCP.2016.21.3.164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
75 Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I. Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab Invest. 2012;92:1020-1032. [PMID: 22525431 DOI: 10.1038/labinvest.2012.75] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 10.1] [Reference Citation Analysis]
76 Joshi N, Kopec AK, Towery K, Williams KJ, Luyendyk JP. The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury. J Pharmacol Exp Ther 2014;349:383-92. [PMID: 24633426 DOI: 10.1124/jpet.113.210880] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
77 Yang Y, Wang Y, Sun J, Zhang J, Guo H, Shi Y, Cheng X, Tang X, Le G. Dietary methionine restriction reduces hepatic steatosis and oxidative stress in high-fat-fed mice by promoting H 2 S production. Food Funct 2019;10:61-77. [DOI: 10.1039/c8fo01629a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 8.3] [Reference Citation Analysis]
78 Shearn CT, Smathers RL, Jiang H, Orlicky DJ, Maclean KN, Petersen DR. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis. J Nutr Biochem 2013;24:1436-45. [PMID: 23465594 DOI: 10.1016/j.jnutbio.2012.12.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
79 Wu KC, Liu J, Klaassen CD. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation. Toxicology and Applied Pharmacology 2012;262:321-9. [DOI: 10.1016/j.taap.2012.05.010] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 8.9] [Reference Citation Analysis]
80 Kanuri G, Wagnerberger S, Landmann M, Prigl E, Hellerbrand C, Bischoff SC, Bergheim I. Effect of acute beer ingestion on the liver: studies in female mice. Eur J Nutr 2015;54:465-74. [DOI: 10.1007/s00394-014-0730-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
81 Beier JI, Guo L, Ritzenthaler JD, Joshi-Barve S, Roman J, Arteel GE.  Fibrin-mediated integrin signaling plays a critical role in hepatic regeneration after partial hepatectomy in mice. Ann Hepatol 2016;15:762-72. [PMID: 27493116 DOI: 10.5604/16652681.1212587] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
82 Ren Y, Geng Y, Chen H, Lu Z, Shi J, Xu Z. Polysaccharide peptides from Coriolus versicolor: A multi-targeted approach for the protection or prevention of alcoholic liver disease. Journal of Functional Foods 2018;40:769-77. [DOI: 10.1016/j.jff.2017.11.051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
83 Guo R, Ren J. Deficiency in AMPK attenuates ethanol-induced cardiac contractile dysfunction through inhibition of autophagosome formation. Cardiovasc Res 2012;94:480-91. [PMID: 22451512 DOI: 10.1093/cvr/cvs127] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
84 Deng X, Luyendyk JP, Ganey PE, Roth RA. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacol Rev 2009;61:262-82. [PMID: 19805476 DOI: 10.1124/pr.109.001727] [Cited by in Crossref: 94] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
85 Beier JI, Luyendyk JP, Guo L, von Montfort C, Staunton DE, Arteel GE. Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology. 2009;49:1545-1553. [PMID: 19291788 DOI: 10.1002/hep.22847] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
86 Cha HN, Choi JH, Kim YW, Kim JY, Ahn MW, Park SY. Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice. Korean J Physiol Pharmacol 2010;14:377-84. [PMID: 21311678 DOI: 10.4196/kjpp.2010.14.6.377] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
87 Tripathi DM, Erice E, Lafoz E, García-Calderó H, Sarin SK, Bosch J, Gracia-Sancho J, García-Pagán JC. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 2015;309:G301-9. [PMID: 26138461 DOI: 10.1152/ajpgi.00010.2015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
88 Ding WX, Manley S, Ni HM. The emerging role of autophagy in alcoholic liver disease. Exp Biol Med (Maywood). 2011;236:546-556. [PMID: 21478210 DOI: 10.1258/ebm.2011.010360] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 7.6] [Reference Citation Analysis]
89 Wu C, Liu J, Tang Y, Li Y, Yan Q, Jiang Z. Hepatoprotective Potential of Partially Hydrolyzed Guar Gum against Acute Alcohol-Induced Liver Injury in Vitro and Vivo. Nutrients 2019;11:E963. [PMID: 31035540 DOI: 10.3390/nu11050963] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
90 Ota S, Horigome K, Ishii T, Nakai M, Hayashi K, Kawamura T, Kishino A, Taiji M, Kimura T. Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism. Biochem Biophys Res Commun 2009;388:311-6. [PMID: 19664596 DOI: 10.1016/j.bbrc.2009.07.164] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
91 Seth D, Hogg PJ, Gorrell MD, McCaughan GW, Haber PS. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. J Hepatol. 2008;48:614-627. [PMID: 18289715 DOI: 10.1016/j.jhep.2007.12.015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
92 Wahlang B, Beier JI, Clair HB, Bellis-Jones HJ, Falkner KC, McClain CJ, Cave MC. Toxicant-associated steatohepatitis. Toxicol Pathol 2013;41:343-60. [PMID: 23262638 DOI: 10.1177/0192623312468517] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 10.5] [Reference Citation Analysis]
93 Gu M, Samuelson DR, Taylor CM, Molina PE, Luo M, Siggins RW, Shellito JE, Welsh DA. Alcohol-associated intestinal dysbiosis alters mucosal-associated invariant T-cell phenotype and function. Alcohol Clin Exp Res 2021;45:934-47. [PMID: 33704802 DOI: 10.1111/acer.14589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Ferolla SM, Armiliato GN, Couto CA, Ferrari TC. The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. Nutrients. 2014;6:5583-5599. [PMID: 25479248 DOI: 10.3390/nu6125583] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
95 Cobo Martín M, Fernández Gil P, Crespo J. [Treatment of fatty liver disease]. Gastroenterol Hepatol 2008;31:229-38. [PMID: 18405489 DOI: 10.1157/13117902] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Spruss A, Bergheim I. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. J Nutr Biochem. 2009;20:657-662. [PMID: 19679262 DOI: 10.1016/j.jnutbio.2009.05.006] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 8.4] [Reference Citation Analysis]
97 Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem. 2011;22:527-534. [PMID: 20801629 DOI: 10.1016/j.jnutbio.2010.04.007] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
98 Hugenholtz GC, Meijers JC, Adelmeijer J, Porte RJ, Lisman T. TAFI deficiency promotes liver damage in murine models of liver failure through defective down-regulation of hepatic inflammation. Thromb Haemost 2013;109:948-55. [PMID: 23467679 DOI: 10.1160/TH12-12-0930] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
99 Kim MS, Ong M, Qu X. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? World J Gastroenterol 2016; 22(1): 8-23 [PMID: 26755857 DOI: 10.3748/wjg.v22.i1.8] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
100 Poole LG, Arteel GE. Transitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver Injury. Biomed Res Int 2016;2016:3162670. [PMID: 27843941 DOI: 10.1155/2016/3162670] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
101 Ghaisas S, Maher J, Kanthasamy A. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 2016;158:52-62. [PMID: 26627987 DOI: 10.1016/j.pharmthera.2015.11.012] [Cited by in Crossref: 208] [Cited by in F6Publishing: 197] [Article Influence: 29.7] [Reference Citation Analysis]
102 Bajt ML, Yan HM, Farhood A, Jaeschke H. Plasminogen activator inhibitor-1 limits liver injury and facilitates regeneration after acetaminophen overdose. Toxicol Sci 2008;104:419-27. [PMID: 18469330 DOI: 10.1093/toxsci/kfn091] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
103 Kita Y, Takamura T, Misu H, Ota T, Kurita S, Takeshita Y, Uno M, Matsuzawa-Nagata N, Kato K, Ando H. Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. PLoS One. 2012;7:e43056. [PMID: 23028442 DOI: 10.1371/journal.pone.0043056] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 8.4] [Reference Citation Analysis]
104 Bae J, Choi WS, Shin CY, Sohn UD. Modulation of the TLR4/MyD88/NF-κB Pathway by Humulus japonicus Extract Protects Against Alcohol-Induced Liver Injury in a Rat Model. J Med Food 2021;24:18-27. [PMID: 33290158 DOI: 10.1089/jmf.2019.4650] [Reference Citation Analysis]
105 Poole LG, Massey VL, Siow DL, Torres-Gonzáles E, Warner NL, Luyendyk JP, Ritzenthaler JD, Roman J, Arteel GE. Plasminogen Activator Inhibitor-1 Is Critical in Alcohol-Enhanced Acute Lung Injury in Mice. Am J Respir Cell Mol Biol 2017;57:315-23. [PMID: 28445073 DOI: 10.1165/rcmb.2016-0184OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
106 Kisfalvi K, Moro A, Sinnett-Smith J, Eibl G, Rozengurt E. Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas. 2013;42:781-785. [PMID: 23462329 DOI: 10.1097/mpa.0b013e31827aec40] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
107 Landmann M, Wagnerberger S, Kanuri G, Ziegenhardt D, Bergheim I. Beer Is Less Harmful for the Liver than Plain Ethanol: Studies in Male Mice Using a Binge-Drinking Model. Alcohol and Alcoholism 2015;50:493-500. [DOI: 10.1093/alcalc/agv048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
108 Engstler AJ, Frahnow T, Kruse M, Pfeiffer AFH, Bergheim I. Plasminogen Activator Inhibitor-1 is Regulated Through Dietary Fat Intake and Heritability: Studies in Twins. Twin Res Hum Genet 2017;20:338-48. [DOI: 10.1017/thg.2017.36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
109 Arteel GE, Guo L, Schlierf T, Beier JI, Kaiser JP, Chen TS, Liu M, Conklin DJ, Miller HL, von Montfort C, States JC. Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice. Toxicol Appl Pharmacol 2008;226:128-39. [PMID: 17919673 DOI: 10.1016/j.taap.2007.08.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
110 Liu J. Ethanol and liver: Recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol 2014; 20(40): 14672-14685 [PMID: 25356030 DOI: 10.3748/wjg.v20.i40.14672] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
111 Wong AK, Howie J, Petrie JR, Lang CC. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin Sci (Lond) 2009;116:607-20. [PMID: 19275766 DOI: 10.1042/CS20080066] [Cited by in Crossref: 111] [Cited by in F6Publishing: 56] [Article Influence: 8.5] [Reference Citation Analysis]
112 Zhang B, Lakshmanan J, Du Y, Smith JW, Harbrecht BG. Cell-specific regulation of iNOS by AMP-activated protein kinase in primary rat hepatocytes. J Surg Res 2018;221:104-12. [PMID: 29229115 DOI: 10.1016/j.jss.2017.08.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
113 Beier JI, Arteel GE, McClain CJ. Advances in alcoholic liver disease. Curr Gastroenterol Rep. 2011;13:56-64. [PMID: 21088999 DOI: 10.1007/s11894-010-0157-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
114 Hu PF, Zhu YW, Zhong W, Chen YX, Lin Y, Zhang X, Yin C, Yue HY, Xie WF. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells. J Gastroenterol Hepatol. 2008;23:1917-1925. [PMID: 18761555 DOI: 10.1111/j.1440-1746.2008.05485.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
115 Ratziu V, Vispo M, Tahiri M, Bonyhay L, de Torres M, Bernhardt C, Poynard T, Lebray P. Peut-on traiter la stéatohépatite métabolique ? Gastroentérologie Clinique et Biologique 2007;31:333-40. [DOI: 10.1016/s0399-8320(07)89386-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Kanuri G, Weber S, Volynets V, Spruss A, Bischoff SC, Bergheim I. Cinnamon extract protects against acute alcohol-induced liver steatosis in mice. J Nutr 2009;139:482-7. [PMID: 19126670 DOI: 10.3945/jn.108.100495] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
117 Ding X, Beier JI, Baldauf KJ, Jokinen JD, Zhong H, Arteel GE. Acute ethanol preexposure promotes liver regeneration after partial hepatectomy in mice by activating ALDH2. Am J Physiol Gastrointest Liver Physiol 2014;306:G37-47. [PMID: 24177029 DOI: 10.1152/ajpgi.00085.2013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
118 Kim YH, Hwang JH, Kim KS, Noh JR, Choi DH, Kim DK, Tadi S, Yim YH, Choi HS, Lee CH. Metformin ameliorates acetaminophen hepatotoxicity via Gadd45β-dependent regulation of JNK signaling in mice. J Hepatol 2015;63:75-82. [PMID: 25681557 DOI: 10.1016/j.jhep.2015.02.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
119 Schmidt RH, Jokinen JD, Massey VL, Falkner KC, Shi X, Yin X, Zhang X, Beier JI, Arteel GE. Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs. J Pharmacol Exp Ther 2013;347:126-35. [PMID: 23926289 DOI: 10.1124/jpet.113.207621] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
120 Yimam M, Jiao P, Hong M, Jia Q. A Standardized Composition from Extracts of Myristica Fragrans , Astragalus Membranaceus , and Poria Cocos Protects Liver from Acute Ethanol Insult. Journal of Medicinal Food 2016;19:780-8. [DOI: 10.1089/jmf.2016.0023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
121 Lu Q, Li X, Liu J, Sun X, Rousselle T, Ren D, Tong N, Li J. AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases. Biosci Rep 2019;39:BSR20181995. [PMID: 30710062 DOI: 10.1042/BSR20181995] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
122 Landmann M, Kanuri G, Spruss A, Stahl C, Bergheim I. Oral intake of chicoric acid reduces acute alcohol-induced hepatic steatosis in mice. Nutrition 2014;30:882-9. [DOI: 10.1016/j.nut.2013.11.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
123 Hoek JB. Metformin and the fate of fat. Gastroenterology 2006;130:2234-7. [PMID: 16762646 DOI: 10.1053/j.gastro.2006.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
124 Bertola A. Rodent models of fatty liver diseases. Liver Research 2018;2:3-13. [DOI: 10.1016/j.livres.2018.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
125 Tran LNK, Kichenadasse G, Sykes PJ. Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions. Curr Cancer Drug Targets 2019;19:368-81. [PMID: 30039761 DOI: 10.2174/1568009618666180724111604] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
126 Yang Y, Zhang H, Yan B, Zhang T, Gao Y, Shi Y, Le G. Health Effects of Dietary Oxidized Tyrosine and Dityrosine Administration in Mice with Nutrimetabolomic Strategies. J Agric Food Chem 2017;65:6957-71. [PMID: 28742334 DOI: 10.1021/acs.jafc.7b02003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
127 Carr RM, Correnti J. Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci. 2015;1353:1-20. [PMID: 25998863 DOI: 10.1111/nyas.12787] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
128 Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, Keshavarzian A, Song BJ. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med. 2013;65:1238-1245. [PMID: 24064383 DOI: 10.1016/j.freeradbiomed.2013.09.009] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 11.8] [Reference Citation Analysis]
129 Syn WK, Teaberry V, Choi SS, Diehl AM. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis 2009;29:200-10. [PMID: 19387919 DOI: 10.1055/s-0029-1214375] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
130 Goldberg RB, Temprosa MG, Mather KJ, Orchard TJ, Kitabchi AE, Watson KE; Diabetes Prevention Program Research Group. Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes. Diabetes Care 2014;37:2253-60. [PMID: 24824548 DOI: 10.2337/dc13-2471] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
131 Luyendyk J, Roth R, Ganey P. Inflammation and Hepatotoxicity. Comprehensive Toxicology. Elsevier; 2010. pp. 295-317. [DOI: 10.1016/b978-0-08-046884-6.01031-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
132 Yang P, Wang Z, Zhan Y, Wang T, Zhou M, Xia L, Yang X, Zhang J. Endogenous A1 adenosine receptor protects mice from acute ethanol-induced hepatotoxicity. Toxicology 2013;309:100-6. [PMID: 23692951 DOI: 10.1016/j.tox.2013.05.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
133 Xun YH, Zhang YJ, Pan QC, Mao RC, Qin YL, Liu HY, Zhang YM, Yu YS, Tang ZH, Lu MJ. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells. J Viral Hepat. 2014;21:597-603. [PMID: 24164660 DOI: 10.1111/jvh.12187] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
134 Oliva J, French SW, Li J, Bardag-Gorce F. Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Exp Mol Pathol 2012;93:26-34. [PMID: 22445925 DOI: 10.1016/j.yexmp.2012.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
135 Li K, Xiao Y, Yu J, Xia T, Liu B, Guo Y, Deng J, Chen S, Wang C, Guo F. Liver-specific Gene Inactivation of the Transcription Factor ATF4 Alleviates Alcoholic Liver Steatosis in Mice. J Biol Chem 2016;291:18536-46. [PMID: 27405764 DOI: 10.1074/jbc.M116.726836] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
136 von Montfort C, Beier JI, Guo L, Kaiser JP, Arteel GE. Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1227-G1234. [PMID: 18325983 DOI: 10.1152/ajpgi.00050.2008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
137 Fu YN, Xiao H, Ma XW, Jiang SY, Xu M, Zhang YY. Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation. Acta Pharmacol Sin 2011;32:879-87. [PMID: 21552292 DOI: 10.1038/aps.2010.229] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
138 Tsukamoto H, Machida K, Dynnyk A, Mkrtchyan H. “Second hit” models of alcoholic liver disease. Semin Liver Dis. 2009;29:178-187. [PMID: 19387917 DOI: 10.1055/s-0029-1214373] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
139 Kaiser JP, Guo L, Beier JI, Zhang J, Bhatnagar A, Arteel GE. PKCε contributes to chronic ethanol-induced steatosis in mice but not inflammation and necrosis. Alcohol Clin Exp Res 2014;38:801-9. [PMID: 24483773 DOI: 10.1111/acer.12324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Landmann M, Sellmann C, Engstler AJ, Ziegenhardt D, Jung F, Brombach C, Bergheim I. Hops ( Humulus lupulus ) Content in Beer Modulates Effects of Beer on the Liver After Acute Ingestion in Female Mice. Alcohol and Alcoholism 2016;52:48-55. [DOI: 10.1093/alcalc/agw060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
141 Tripathi SS, Singh S, Garg G, Kumar R, Verma AK, Singh AK, Bissoyi A, Rizvi SI. Metformin ameliorates acetaminophen-induced sub-acute toxicity via antioxidant property. Drug Chem Toxicol 2019;:1-9. [PMID: 31474151 DOI: 10.1080/01480545.2019.1658769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
142 Kato J, Okamoto T, Motoyama H, Uchiyama R, Kirchhofer D, Van Rooijen N, Enomoto H, Nishiguchi S, Kawada N, Fujimoto J, Tsutsui H. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology 2013;57:362-72. [DOI: 10.1002/hep.26027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
143 Shukla SD, Pruett SB, Szabo G, Arteel GE. Binge ethanol and liver: new molecular developments. Alcohol Clin Exp Res. 2013;37:550-557. [PMID: 23347137 DOI: 10.1111/acer.12011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 6.2] [Reference Citation Analysis]
144 Albano E. New concepts in the pathogenesis of alcoholic liver disease. Expert Review of Gastroenterology & Hepatology 2014;2:749-59. [DOI: 10.1586/17474124.2.6.749] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
145 Seth D, Haber PS, Syn WK, Diehl AM, Day CP. Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J Gastroenterol Hepatol. 2011;26:1089-1105. [PMID: 21545524 DOI: 10.1111/j.1440-1746.2011.06756.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 9.1] [Reference Citation Analysis]